Peptides,GLP-1,GIP,Simeglutide,Semaglutide,Tirzepatide,Liraglutide,Retatrutide,Acetyl hexapeptide,Leuprorelin Acetate

Retatrutide

Retatrutide is an experimental drug for obesity developed. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors). It has been shown to achieve a more than 17.5% mean weight reduction in adults without diabetes but with obesity or preobesity (overweight) during a phase 2 trial.

Product Name: Retatrutide

CAS: 2381089-83-2

Shippment：Air shipping

Package: at customer requirement

Storage: 2-8°C

Send Email

Chat Now

Share With:

Product Classification

Sterile Vial

Sterile vacuum vial

Ready to use products

Pharmaceutical packaging

Peptides

Chromatography Consumables

Phone: +86 18892696988

E-mail: info@steriscience.net

E-mail: sales@steriscience.net

Add:Block C, Building 35, Tanjing Commercial Center, Baiyun Street, Kecheng District, Quzhou City, Zhejiang Province, China

Product Description

Product name: Retatrutide
CAS: 2381089-83-2
Storage: 2-8°C
Package：1mg/bottle, 5mg/bottle ,10mg/bottle,or at customer requirement
Delivery term：2-3Weeks
Shippment：Air shipping
After-sale technical servives provided
Customers' commercial secrets absolutely protected
For research purposes

Retatrutide is an experimental drug for obesity developed. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors). It has been shown to achieve a more than 17.5% mean weight reduction in adults without diabetes but with obesity or preobesity (overweight) during a phase 2 trial.